MyVal

Myval™ The transcatheter heart valve (THV) is intended for the treatment of patients with aortic stenosis. Unique "hybrid honeycomb" valve design using PET technology provides high hemodynamic performance and minimizes paravalvular leakage. Myval THV is designed for the most precise positioning and reliable deployment, providing optimal clinical results in patients with severe aortic stenosis. Available in a wide range of sizes, which allows you to take into account the individual anatomical features of the patient and select a personalized solution in each specific case.